Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports

OBJECTIVE: In the light of the recent United States Food and Drug Administration (FDA) warning to clinicians on using previously approved doses of citalopram because of the purported higher risk of torsade de pointes (TdP), we pursued the broader question: are selective serotonin reuptake inhibitor...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Kogut, Christopher, Crouse, Ericka Breden, Vieweg, W. Victor R., Hasnain, Mehrul, Baranchuk, Adrian, Digby, Geneviève C., Koneru, Jayanthi N., Fernandez, Antony, Deshmukh, Anand, Hancox, Jules C., Pandurangi, Ananda K.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: SAGE Publications 2013
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125314/
https://ncbi.nlm.nih.gov/pubmed/25114780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098613492366
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन